Charming Medical Limited (MCTA)

Charming Medical Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Net Income	1.2	0.78	-0.31
Depreciation & Amortization	0.26	0.39	0.21
Loss (Gain) From Sale of Investments	-0	-	-
Other Operating Activities	0.13	0.07	0.03
Change in Accounts Receivable	-0.04	-0.16	-0.15
Change in Inventory	0	0.04	-0.06
Change in Accounts Payable	-0.2	0.21	0.18
Change in Unearned Revenue	-1.06	-1.11	2.73
Change in Income Taxes	0.1	0.12	-
Change in Other Net Operating Assets	0.04	-0.04	-0.11
Operating Cash Flow	0.43	0.3	2.43
Operating Cash Flow Growth	44.16%	-87.86%	-
Capital Expenditures	-0.29	-0.21	-0.61
Investment in Securities	-1.94	-	-
Investing Cash Flow	-2.23	-0.21	-0.61
Long-Term Debt Issued	0.21	0.04	-
Short-Term Debt Repaid	-0.13	-0.15	-0.18
Long-Term Debt Repaid	-0.03	-0.01	-
Total Debt Repaid	-0.16	-0.15	-0.18
Net Debt Issued (Repaid)	0.05	-0.12	-0.18
Other Financing Activities	0.47	0.22	-1.25
Financing Cash Flow	0.52	0.1	-1.43
Foreign Exchange Rate Adjustments	-0	-0.01	0.01
Net Cash Flow	-1.29	0.17	0.4
Free Cash Flow	0.14	0.08	1.83
Free Cash Flow Growth	63.10%	-95.36%	-
Free Cash Flow Margin	2.22%	1.41%	51.76%
Free Cash Flow Per Share	0.01	0.01	0.12
Cash Interest Paid	0.02	0.03	0.02
Levered Free Cash Flow	1	0.75	-
Unlevered Free Cash Flow	1.01	0.76	-
Change in Working Capital	-1.16	-0.94	2.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q